Beryllium-specific CD4+ T cells induced by chemokine neoantigens perpetuate inflammation is a research paper published in Journal of Clinical Investigation (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: HL62410,HL152756,HL102245,ES025534
NHLBI NIH HHS
Grant: K24 HL102245
NHLBI NIH HHS
Grant: R01 HL152756
NIEHS NIH HHS
Grant: R01 ES025534
NIDDK NIH HHS
Grant: R01 DK099317
NHLBI NIH HHS
Grant: R01 HL062410
NHLBI NIH HHS
Grant: R01 HL136137
National Institutes of Health
Grant: 5K24HL102245-04
Patient-Oriented Research in Beryllium-Induced Disease
National Institutes of Health
Grant: 5R01ES025534-02
Interactions between antigen-specific effector and regulatory T cells in beryllium-induced disease
National Institutes of Health
Grant: 1R01HL062410-01
PATHOGENIC T CELLS IN CHRONIC BERYLLIUM DISEASE
National Institutes of Health
Grant: 5R01HL152756-04
Role of Chemokines in Innate and Adaptive Immunity in the Lung
Fields of Study
MeSH Terms
Keywords